VBIV - VBI Vaccines GAAP EPS of -$3.22 revenue of $0.49M May, 15 2023 09:23 AM VBI Vaccines Inc. 2023-05-15 09:23:24 ET VBI Vaccines press release ( NASDAQ: VBIV ): Q1 GAAP EPS of -$3.22. Revenue of $0.49M (+276.9% Y/Y). For further details see: VBI Vaccines GAAP EPS of -$3.22, revenue of $0.49M